---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-048696"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:01:15.560998+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics enters retention bonus agreement with CAO Joel Sussman for up to $250,000

## Summary
- Up to $250,000 in retention bonuses tied to timely completion and filing of reporting obligations.
- Retention payments reduce severance payments under existing employment agreement dollar-for-dollar.
- Unpaid bonus accelerates if involuntary termination (not for cause) or good reason occurs.
- Agreement dated February 6, 2026, with payments tied to specific conditions.

## SEC filing metadata
- accession: 0001193125-26-048696
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312526048696/0001193125-26-048696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312526048696/d892515d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-048696
- JSON: https://secwatch.observer/filing/0001193125-26-048696.json
- Plain text: https://secwatch.observer/filing/0001193125-26-048696.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.